Stay updated on ELVN-001 for CML Treatment Clinical Trial
Sign up to get notified when there's something new on the ELVN-001 for CML Treatment Clinical Trial page.

Latest updates to the ELVN-001 for CML Treatment Clinical Trial page
- Check6 days agoChange DetectedThe clinical trial record for ELVN-001 is displayed, with details about the study, participant eligibility, locations, and planned measures. Previously, the page showed a forbidden-access error.SummaryDifference96%

- Check13 days agoNo Change Detected
- Check20 days agoChange DetectedThe footer revision label changed from v3.7.2 to v3.8.0 while the study page continued to display a 403 Forbidden error.SummaryDifference0.2%

- Check26 days agoChange DetectedA site-wide NIH notice announces a transition from using “Artificial Intelligence” to “Super Intelligence” terminology across NIH content.SummaryDifference1%

- Check33 days agoChange DetectedThe ClinicalTrials.gov footer revision identifier changes from v3.7.1 to v3.7.2, while the page continues to display a 403 error.SummaryDifference0.2%

- Check40 days agoChange DetectedThe footer revision identifier changes from v3.7.0 to v3.7.1 on the 403 Forbidden page.SummaryDifference0.2%

- Check54 days agoChange DetectedThe study page now displays a 403 Forbidden error, replacing the previous study details with a blocked access message. This indicates that the trial information on this page is not currently viewable by users.SummaryDifference20%

Stay in the know with updates to ELVN-001 for CML Treatment Clinical Trial
Enter your email address, and we'll notify you when there's something new on the ELVN-001 for CML Treatment Clinical Trial page.